Astellas Pharma, Inc.Astellas Pharma, Inc.Astellas Pharma, Inc.

Astellas Pharma, Inc.

No trades
See on Supercharts

Price target

12.730.000.00%
The 13 analysts offering 1 year price forecasts for ALPMY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 14 analysts giving stock ratings to ALPMY in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned